SS
RCKT icon

SBI Securities’s Rocket Pharmaceuticals RCKT Stock Holding History

SBI Securities’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$910 Hold
266
– – ﹤0.01% 2838
2026
Q1 		$952 Buy
266
+149
+127% +$592 ﹤0.01% 2675
2025
Q4 		$411 Sell
117
-118
-50% -$404 ﹤0.01% 2946
2025
Q3 		$766 Sell
235
-11
-4% -$35 ﹤0.01% 2803
2025
Q2 		$603 Sell
246
-104
-30% -$527 ﹤0.01% 2893
2025
Q1 		$2.33K Buy
350
+300
+600% +$2.96K ﹤0.01% 2222
2024
Q4 		$629 Buy
+50
New +$753 ﹤0.01% 2813

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

SBI Securities's RCKT Position: Q2 2026 in Review

SBI Securities held its Rocket Pharmaceuticals (RCKT) position steady in Q2 2026 at 266 shares worth $910. The position accounts for ﹤0.01% of the portfolio, ranked #2838.

SBI Securities first reported a position in RCKT in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.33K in Q1 2025. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • SBI Securities held 266 shares of Rocket Pharmaceuticals worth $910 as of Q2 2026.
  • SBI Securities left its Rocket Pharmaceuticals share count unchanged in Q2 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2838 holding.
  • SBI Securities first reported a position in Rocket Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Rocket Pharmaceuticals position peaked at $2.33K in Q1 2025.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.